![Lucas_Mercanti_FinalUpdated_[3373]](https://wb65d28bwow3dv4kc1srch6a-wpengine.netdna-ssl.com/wp-content/uploads/2018/07/Lucas_Mercanti_FinalUpdated_3373.png)
May 4, 2020
INSIGHT: FDA Exclusivities Add Incentives to Covid-19 Drug Race By Steven D. Roth, Bloomberg Law, May 4, 2020 Drugmakers are racing to develop a treatment for […]
March 10, 2020
Trademark Specimen Requirements to Demonstrate Use By Elizabeth Lee D’Amore, March 2020 Generally, an applicant is required to submit to the United States Patent and Trademark […]
February 12, 2020
The Long Odds Of Obtaining IPR Reversals On Issues Of Fact By Steven Roth (Law360, February 11, 2020) Obtaining a reversal of a decision of the […]
July 13, 2019
Michael Mercanti Earns Ranking in Latest Edition of IAM Patent 1000 07/13/2019 | Lucas & Mercanti co-founder Michael Mercanti is recommended in the 2019 edition of […]
February 14, 2018
Lucas & Mercanti, LLP Names Two New Partners and Counsel, Expands Pharmaceutical Litigation Practice
Lucas & Mercanti, LLP Names Two New Partners and Counsel, Expands Pharmaceutical Litigation Practice 02/14/2018 | Lucas & Mercanti, LLP David J. Galluzzo and Steven D. […]
January 2, 2018
David James Galluzzo, Esq. is Now a Partner at Lucas & Mercanti, LLP 01/02/2018 New York, January 2, 2018: The partners of Lucas & Mercanti, LLP, […]
July 25, 2017
Michael Mercanti Earns Ranking in Latest Edition of IAM Patent 1000 07/25/2017 | Lucas & Mercanti co-founder Michael Mercanti is recommended in the 2017 edition of […]
January 23, 2017
The USPTO Implements New Rules and Fees 01/23/2017 | Elizabeth Lee D’Amore With the objective of moving towards a fully integrated, paperless system, including promoting efficiency […]
June 8, 2016
Lucas & Mercanti LLP announced today that Elizabeth Lee D’Amore has been elected partner. 06/08/2016 | Lucas & Mercanti, LLP Ms. Lee D’Amore joined the firm […]